$3.04
-0.27-8.16%
Last update: Oct 30, 4:03 PM
BriaCell Therapeutics Corp (BCTX) Stock Price, Quote, News & History
BCTXNASDAQ
You can purchase shares of BriaCell Therapeutics (NASDAQ:BCTX) through any online brokerage.
Other companies in BriaCell Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BriaCell Therapeutics has a consensus price target of $40.00.
The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $3.04 last updated October 30, 2026 at 4:03 PM EDT.
There are no upcoming dividends for BriaCell Therapeutics.
BriaCell Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for BriaCell Therapeutics.
BriaCell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing targeted immunotherapies to transform cancer care. Its Bria-IMT targeted immunotherapy is being developed in combination with the immune checkpoint inhibitor Retifanlimab...
